Detection of human cytomegalovirus genome and gene products in central nervous system tumours

Br J Cancer. 2005 Feb 28;92(4):747-50. doi: 10.1038/sj.bjc.6602339.

Abstract

Human cytomegalovirus (HCMV) genome and related proteins have been reported in a great proportion of malignant gliomas. However, these results are unexpected since HCMV is not known as an oncogenic virus. By immunohistochemistry (with an anti-IE1 monoclonal antibody) and in situ hybridisation (with biotinylated DNA probes) on tissue microarrays and frozen sections, we investigated a French series of central nervous system (CNS) tumours, including 97 glioblastomas. In 10 cases of glioblastoma, rare astrocyte-like cells, admixed with tumour cells, stained positively for HCMV and in one case a doubtful staining of rare cells was noticed. This may indicate a reactivation of the virus under local immunosuppression but none of the cases of CNS tumours (n=132) contained HCMV genomes and/or proteins in a significant proportion of tumour cells. Our results strongly suggest that HCMV is unlikely to be implicated in the development of human malignant gliomas, at least in French cases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Central Nervous System Neoplasms / virology*
  • Cytomegalovirus / genetics*
  • Cytomegalovirus / isolation & purification*
  • Cytomegalovirus Infections / complications
  • Cytomegalovirus Infections / diagnosis*
  • DNA, Viral / isolation & purification*
  • Female
  • Genome, Viral*
  • Glioblastoma / virology
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization
  • Male
  • Middle Aged
  • Oligonucleotide Array Sequence Analysis

Substances

  • DNA, Viral